SYDNEY, AUSTRALIA, March 20, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases ...
LOS ANGELES, Nov. 14, 2022 /PRNewswire/ -- Stand Up To Cancer ® (SU2C) announced today the launch of a new public service announcement (PSA) campaign in partnership with Jazz Pharmaceuticals plc (JAZZ ...
MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results